Gagandeep Mallah-Singh
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Cyclic Glycine-Proline (cGP) Normalises Insulin-Like Growth Factor-1 (IGF-1) Function: Clinical Significance in the Ageing Brain and in Age-Related Neurological Conditions.
Journal: Molecules (Basel, Switzerland)
Published: November 14, 2022
Administration of cyclic glycine-proline during infancy improves adult spatial memory, astrocyte plasticity, vascularization and GluR-1 expression in rats.
Journal: Nutritional neuroscience
Published: September 27, 2021
N-Acetyl Cysteine Restores Sirtuin-6 and Decreases HMGB1 Release Following Lipopolysaccharide-Sensitized Hypoxic-Ischemic Brain Injury in Neonatal Mice.
Journal: Frontiers in cellular neuroscience
Published: July 17, 2021
A Model of Germinal Matrix Hemorrhage in Preterm Rat Pups.
Journal: Frontiers in cellular neuroscience
Published: February 15, 2020
The Role of Mitochondrial and Endoplasmic Reticulum Reactive Oxygen Species Production in Models of Perinatal Brain Injury.
Journal: Antioxidants & redox signaling
Published: April 09, 2019
The role for cyclic Glycine-Proline, a biological regulator of insulin-like growth factor-1 in pregnancy-related obesity and weight changes.
Journal: Journal of biological regulators and homeostatic agents
Published: June 21, 2018
Cyclic-glycine-proline accelerates mammary involution by promoting apoptosis and inhibiting IGF-1 function.
Journal: Journal of cellular physiology
Published: October 31, 2016
Maternally Administered Cyclic Glycine-Proline Increases Insulin-Like Growth Factor-1 Bioavailability and Novelty Recognition in Developing Offspring.
Journal: Endocrinology
Published: June 30, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026